Quantification of a bifunctional drug in the presence of an immune response: a ligand-binding assay specific for 'active' drug.
about
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3 - LBA, biomarkers and immunogenicity).Evaluation of the potential use of hybrid LC-MS/MS for active drug quantification applying the 'free analyte QC concept'.3-(4-Hydroxyphenyl)propionic acid: the forgotten detection substrate for ligand-binding assay-based bioanalysis.Platform switching from ELISA to Gyrolab™: a novel generic reagent omits the need to change critical reagents.
P2860
Quantification of a bifunctional drug in the presence of an immune response: a ligand-binding assay specific for 'active' drug.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Quantification of a bifunction ...... ay specific for 'active' drug.
@en
Quantification of a bifunction ...... ay specific for 'active' drug.
@nl
type
label
Quantification of a bifunction ...... ay specific for 'active' drug.
@en
Quantification of a bifunction ...... ay specific for 'active' drug.
@nl
prefLabel
Quantification of a bifunction ...... ay specific for 'active' drug.
@en
Quantification of a bifunction ...... ay specific for 'active' drug.
@nl
P2093
P2860
P356
P1433
P1476
Quantification of a bifunction ...... ay specific for 'active' drug.
@en
P2093
Apollon Papadimitriou
Gregor Jordan
Julia Heinrich
Maria Viert
Martin Schäfer
Roland F Staack
P2860
P304
P356
10.4155/BIO.15.213
P577
2015-10-20T00:00:00Z